DNMR - Danimer Scientific GAAP EPS of -$0.30 misses by $0.03 revenue of $12.7M misses by $2.66M
- Danimer Scientific press release ( NYSE: DNMR ): Q2 GAAP EPS of -$0.30 misses by $0.03 .
- Revenue of $12.7M (-12.2% Y/Y) misses by $2.66M .
- For the full year 2022, the Company reaffirms its outlook for Adjusted EBITDA to be in the range of $(45) million to $(35) million, compared to $(22.6) million in 2021.
- The Company now expects full year capital expenditures to be in the range of $175 million to $185 million, inclusive of capitalized interest and internal labor and overhead, with a year-end cash balance in excess of $60 million.
For further details see:
Danimer Scientific GAAP EPS of -$0.30 misses by $0.03, revenue of $12.7M misses by $2.66M